Mia's Feed
Medical News & Research

US Ends Use of Vaccine Ingredient Targeted by Anti-Vaccine Movements

US Ends Use of Vaccine Ingredient Targeted by Anti-Vaccine Movements

Share this article

The US has decided to end the use of thimerosal, a preservative once targeted by anti-vaccine groups, after scientific reviews confirmed its safety, aiming to improve vaccine confidence.

2 min read

The United States health authorities have announced the discontinuation of a vaccine ingredient that has long been the focus of anti-vaccine conspiracy theories. This decision comes after substantial scientific studies and expert reviews confirmed the safety of the ingredient, which was falsely believed by some groups to cause autism and other health problems.

The ingredient in question is thimerosal, a preservative used to prevent bacterial and fungal contamination in multidose vaccine vials. Extensive research, including assessments by the World Health Organization, has shown that thimerosal does not pose any health risk. Despite this, it has been a target of misinformation, prompting the CDC and other health organizations to reassess its use.

Following a recent panel review convened by vaccine advocate Robert F. Kennedy Jr., experts recommended phasing out thimerosal in influenza vaccines used for children, pregnant women, and adults. Earlier, the FDA had already limited the use of thimerosal in many vaccines available in the US. However, the new policy is seen as a step to address public concerns and combat vaccine hesitancy fueled by misinformation.

The move reflects broader efforts to bolster vaccine confidence and ensure public health safety. Health officials emphasize that vaccines are rigorously tested for safety and efficacy, and the removal of a preservative that is widely regarded as safe is unlikely to impact vaccine protection. Experts warn that continued misinformation can harm vaccination efforts, but committing to transparent and evidence-based policies remains key.

For more detailed insights, visit: https://medicalxpress.com/news/2025-07-vaccine-ingredient-anti-vaxxers.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

University Enhances Surveillance for Emerging Infectious Diseases

The University of Minnesota is establishing a new institute to track emerging infectious threats through genetic surveillance and wastewater analysis, strengthening disease monitoring capabilities amid federal funding challenges. Learn about their innovative approach to early outbreak detection.

New Molecular Testing Reveals Advances in Brain Cancer in Adolescents and Young Adults

Molecular testing is revolutionizing brain cancer diagnosis and treatment strategies in adolescents and young adults by uncovering genetic profiles that inform early and targeted interventions.

Blood Vessels and Immune Cells in the Brain: Dual Roles in Protection and Disease Risk

Recent scientific advances reveal that blood vessels and immune cells in the brain play a dual role—protecting brain health while also contributing to the risk of Alzheimer's and stroke. Explore how these guardian cells influence neurological diseases and potential new treatments.

Innovative Brain Tumor Gene Expression Database Accelerates Treatment Discovery

A groundbreaking genomic atlas of nervous system tumors offers new insights into tumor classification and potential targeted therapies, accelerating research and treatment development for brain and nerve cancers.